Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Noci

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|April 17, 2024
Rejoinder to the letter: "Standard and reference-based conditional mean imputation: Regulators and trial statisticians be aware!"Marcel Wolbers, Alessandro Noci, Paul Delmar, et al.
Pharmaceutical Statistics|May 19, 2022
Standard and reference-based conditional mean imputationMarcel Wolbers, Alessandro Noci, Paul Delmar, et al.
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|April 17, 2024
Rejoinder to the letter: "Standard and reference-based conditional mean imputation: Regulators and trial statisticians be aware!"Marcel Wolbers, Alessandro Noci, Paul Delmar, et al.
Pharmaceutical Statistics|May 19, 2022
Standard and reference-based conditional mean imputationMarcel Wolbers, Alessandro Noci, Paul Delmar, et al.
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Pageof 1